Skip to main content
Fig. 9 | BMC Cancer

Fig. 9

From: A pan-cancer analysis of the oncogenic role of ERCC6L

Fig. 9

Methylation of ERCC6L promoter was correlated with improved prognosis in BRCA patients. A Comparison of ERCC6L promoter methylation levels in normal tissue and BRCA tumor samples. B Correlation analysis of ERCC6L promoter methylation and mRNA expression levels in BRCA cohorts. C, D Correlation analysis of the indicated ERCC6L promoter methylation sites and ERCC6L mRNA expression levels in BRCA cohorts. F–H Overall survival analysis of BRCA patients stratified by ERCC6L promoter methylation levels at three methylation sites

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us